
T-Cell Immunotherapy Markets to 2024: Lucrative Opportunities from Rapidly Increasing R&D Activities - ResearchAndMarkets.com
The "T-Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global t-cell immunotherapy market to grow with a healthy CAGR over the forecast period of 2018-2024.
The study on t-cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Market Dynamics
Drivers
- Growing Occurrence of Cancer in both Children as well as in Adults
- On-Going Development to Improve Existing Therapies
Restraints
- Neurological Problems Associated with T-cell Immunotherapy
Opportunities
- Rapidly Increasing Research & Development Activities
- Technological Advancement in Cancer Treatment
Segments Covered
Mechanism of Action
- Active Immunotherapy
- Passive Immunotherapy
Type of Therapy
- CAR-T
- TCR
- TIL
Product Class
- Monoclonal Antibodies
- Oncolytic Virus Therapy
- Bispecific Antibodies
- Cytokines
Companies Profiled
- Adaptimmune Therapeutics
- Bluebird Bio
- Innovative Cellular Therapeutics
- Novartis
- Sinobioway Cell Therapy
- Cellectis
- CARsgen Therapeutics
- Autolus
- Celgene
Key Topics Covered
1. Preface
2. Executive Summary
3. Global T-Cell Immunotherapy Market Overview
4. T-Cell Immunotherapy Market Macro Indicator Analysis
5. Global T-Cell Immunotherapy Market by Mechanism of Action
6. Global T-Cell Immunotherapy Market by Type of Therapy
7. Global T-Cell Immunotherapy Market by Product Class
8. Global T-Cell Immunotherapy Market by Region
9. Company Profiles and Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/9dfcs5/tcell?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181106005556/en/
Editor Details
-
Company:
- Business Wire
- Website: